Literature DB >> 9614962

[Therapy results of the British ET-1 study for Ewing's sarcoma].

J Dunst.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9614962     DOI： 10.1007/bf03038726

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  4 in total

1.  Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party.

Authors:  A W Craft; S J Cotterill; J A Bullimore; D Pearson
Journal:  Eur J Cancer       Date:  1997-06       Impact factor: 9.162

Review 2.  Ewing's sarcoma. Prognostic factors, disease control, and the reemerging role of surgical treatment.

Authors:  M I O'Connor; D J Pritchard
Journal:  Clin Orthop Relat Res       Date:  1991-01       Impact factor: 4.176

Review 3.  [Therapy of Ewing's sarcoma].

Authors:  J Dunst; R Sauer
Journal:  Strahlenther Onkol       Date:  1993-12       Impact factor: 3.621

4.  Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial.

Authors:  J Dunst; H Jürgens; R Sauer; H Pape; M Paulussen; W Winkelmann; C Rübe
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-07-15       Impact factor: 7.038
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.